All In Biotech

Drug Trial Radar · NCT06143904

A Study to Evaluate Absolute Bioavailability, Absorption, Metabolism, and Excretion of Genz-112638 in Healthy Male Participants

An Open-Label Study to Evaluate the Absolute Bioavailability of Genz-112638 and the Absorption, Metabolism, and Excretion of [14C]-Genz-112638 in Male Subjects

Last checked: Nov 20, 2026Latest source record: Nov 22, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

10

Actual

Start

Jun 3, 2009

Primary completion

Jul 5, 2009

Study completion Jul 5, 2009

Sponsor

Lead sponsor
SanofiSanofi (SNY)
Sponsor type
Industry
First posted
Nov 22, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Basic science
FDA-regulated drug
Yes
Who can join
Male only, from 18 years, up to 45 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Objectives: To determine pharmacokinetic (PK) variables, including absolute bioavailability (F), of Genz-99067, the free base of the L-tartaric acid salt of Genz-112638 as it exists in plasma, after a single intravenous (IV) dose and after a single oral dose of Genz-112638 (unlabeled). To determine the PK, total recovery, routes and rates of excretion, and the metabolic profile of Genz-99067 after 5 days of BID oral dosing with unlabeled Genz-112638 followed by a single dose of \[14C\]-Genz-112638.

Conditions

  • Gaucher's Disease Type I

Interventions

  • Genz-112638Drug

    Pharmaceutical form:Solution-Route of administration:IV

  • Genz-112638Drug

    Pharmaceutical form:Capsule-Route of administration:Oral

  • [14C]-Genz-112638Drug

    Pharmaceutical form:Solution-Route of administration:Oral

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Assessment of pharmacokinetic (PK) parameter: CmaxTime frame: Multiple timepoints up to Day 26
  2. Assessment of pharmacokinetic (PK) parameter: TmaxTime frame: Multiple timepoints up to Day 26
  3. Assessment of pharmacokinetic (PK) parameter: AUC0-∞Time frame: Multiple timepoints up to Day 26
  4. Assessment of pharmacokinetic (PK) parameter: AUC0 -τTime frame: Multiple timepoints up to Day 26
  5. Assessment of pharmacokinetic (PK) parameter: AUC0-∞/DTime frame: Multiple timepoints up to Day 26
  6. Assessment of pharmacokinetic (PK) parameter: AUC0-τ/DTime frame: Multiple timepoints up to Day 26
  7. Assessment of pharmacokinetic (PK) parameter: FTime frame: Multiple timepoints up to Day 26
  8. Assessment of pharmacokinetic (PK) parameter: CL/FTime frame: Multiple timepoints up to Day 26
  9. Assessment of pharmacokinetic (PK) parameter: t½Time frame: Multiple timepoints up to Day 26
  10. Pharmacokinetic (PK) parameter: Absolute bioavailability (F) of single-dose oral versus single-dose IV administrationTime frame: Multiple timepoints up to Day 26
  11. Assessment of pharmacokinetic (PK) parameter: Total radioactivity excreted in urine and fecesTime frame: Multiple timepoints up to Day 26
  12. Assessment of pharmacokinetic (PK) parameter: Total radioactivity in whole blood and plasmaTime frame: Multiple timepoints up to Day 26
  13. Assessment of pharmacokinetic (PK) parameter: % relative abundance of each component in samples of plasma or excretaTime frame: Multiple timepoints up to Day 26
  14. Assessment of pharmacokinetic (PK) parameter: The percentage of the administered dose attributed to each component in samples of urine or fecesTime frame: Multiple timepoints up to Day 26
  15. Assessment of pharmacokinetic (PK) parameter: The radioactivity of [14C]-Genz-99067 and each major metabolite in plasma, as identified by radio-profilingTime frame: Multiple timepoints up to Day 26
  16. Noncompartmental PK parameters: AUC0-tTime frame: Multiple timepoints up to Day 26
  17. Noncompartmental PK parameters: AUC0-∞Time frame: Multiple timepoints up to Day 26
  18. Noncompartmental PK parameters: CmaxTime frame: Multiple timepoints up to Day 26
  19. Noncompartmental PK parameters: TmaxTime frame: Multiple timepoints up to Day 26
  20. Noncompartmental PK parameters: t½Time frame: Multiple timepoints up to Day 26
  21. Noncompartmental PK parameters: Vz/FTime frame: Multiple timepoints up to Day 26
  22. Noncompartmental PK parameters: CL/FTime frame: Multiple timepoints up to Day 26
  23. Noncompartmental PK parameters for urine and feces: Cum AeTime frame: Multiple timepoints up to Day 26
  24. Noncompartmental PK parameters for urine and feces: % doseTime frame: Multiple timepoints up to Day 26
  25. Renal clearance (CLR) for total plasma radioactivity and Genz-99067Time frame: Multiple timepoints up to Day 26
  26. PK parameters [AUC0-τ, AUC0-∞, Cmax, Tmax, t½] and metabolite ratio for metabolite(s) of Genz-99067Time frame: Multiple timepoints up to Day 26

Locations

No sites are listed on the registry yet.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.